We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
-6.36%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$535M
AUM Growth
+$62.7M
(+13%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
19.67%
Top 10 Holdings %
Top 10 Hldgs %
63.47%
Holding
194
New
34
Increased
59
Reduced
58
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$108M |
| 2 |
Amazon
AMZN
|
+$7.38M |
| 3 |
Gilead Sciences
GILD
|
+$5.55M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.78M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$4.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$4.83M |
| 2 |
INFA
INFORMATICA CORP
INFA
|
+$4.71M |
| 3 |
Las Vegas Sands
LVS
|
+$3.68M |
| 4 |
Qualcomm
QCOM
|
+$3.44M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$3.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 11.89% |
| 2 | Technology | 9.56% |
| 3 | Financials | 7.95% |
| 4 | Communication Services | 7% |
| 5 | Healthcare | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
101
DELISTED
Aetna Inc
AET
| $457K | 0.09% |
+4,181
| New | +$483K |
|
102
Open Text
OTEX
$5.8B
| $454K | 0.08% |
20,272
-44,546
| -69% | -$963K |
|
103
Elevance Health
ELV
$86.6B
| $362K | 0.07% |
+2,586
| New | +$389K |
|
|
TPH
104
DELISTED
Tri Pointe Homes
TPH
| $339K | 0.06% |
25,873
+2,856
| +12% | +$41.4K |
|
|
NETI
105
DELISTED
Eneti Inc.
NETI
| $324K | 0.06% |
1,992
+971
| +95% | +$181K |
|
|
YHOO
106
DELISTED
Yahoo Inc
YHOO
| $318K | 0.06% |
10,997
+1,148
| +12% | +$39.8K |
|
107
Liberty Media Series C
FWONK
$26B
| $300K | 0.06% |
12,302
-710
| -5% | -$18.2K |
|
108
Liberty Global Class A
LBTYA
$3.55B
| $285K | 0.05% |
7,596
+780
| +11% | +$33.9K |
|
109
Macy's
M
$6.26B
| $285K | 0.05% |
5,563
-2,559
| -32% | -$161K |
|
|
FISV
110
Fiserv Inc
FISV
$27.4B
| $260K | 0.05% |
+6,000
| New | +$260K |
|
111
Vertex Pharmaceuticals
VRTX
$133B
| $258K | 0.05% |
2,473
-131
| -5% | -$16.8K |
|
112
Avis
CAR
$4.93B
| $255K | 0.05% |
5,827
+1,630
| +39% | +$70.7K |
|
113
Ameriprise Financial
AMP
$49.9B
| $242K | 0.05% |
+2,220
| New | +$262K |
|
114
Baidu
BIDU
$35.6B
| $240K | 0.04% |
1,749
-1,818
| -51% | -$300K |
|
|
SC
115
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $240K | 0.04% |
11,736
+1,348
| +13% | +$31K |
|
116
DigitalBridge
DBRG
$2.95B
| $237K | 0.04% |
4,118
+290
| +8% | +$20.3K |
|
|
SEMI
117
DELISTED
SunEdison Semiconductor Limited
SEMI
| $211K | 0.04% |
20,055
+7,374
| +58% | +$99.3K |
|
|
MDAS
118
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $211K | 0.04% |
10,509
-493
| -4% | -$10.5K |
|
119
Universal Health Services
UHS
$10.2B
| $207K | 0.04% |
+1,655
| New | +$230K |
|
120
Biogen
BIIB
$30.9B
| $203K | 0.04% |
+696
| New | +$230K |
|
|
WLL
121
DELISTED
Whiting Petroleum Corporation
WLL
| $180K | 0.03% |
+39
| New | +$241K |
|
|
IM
122
DELISTED
Ingram Micro
IM
| $179K | 0.03% |
6,561
+1,240
| +23% | +$32.2K |
|
123
Dillards
DDS
$9.93B
| $177K | 0.03% |
+2,024
| New | +$196K |
|
124
NXP Semiconductors
NXPI
$58.9B
| $171K | 0.03% |
1,964
-4,534
| -70% | -$409K |
|
125
Williams Companies
WMB
$90.1B
| $168K | 0.03% |
+4,560
| New | +$227K |
|
Similar funds
VM
SSC
ACM
MCM
MIA
SP
SWC
VIS
Howard Hughes Medical Institute's Q3 2015 Portfolio in Review
As of Q3 2015, Howard Hughes Medical Institute held 194 positions worth $535M, up 13% from $472M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Howard Hughes Medical Institute deployed $105M of net new capital in Q3 2015, opening 34 new positions and adding to 59 existing holdings. Its largest new stake was Gilead Sciences: 50,000 shares worth $4.91M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $3.19M trimmed.
- Howard Hughes Medical Institute's largest Q3 2015 buy was Gilead Sciences: 50,000 shares worth $4.91M.
- Howard Hughes Medical Institute added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $108M increase.
- Howard Hughes Medical Institute's biggest Q3 2015 reduction was Bank of New York Mellon, cutting an estimated $3.19M.
- Howard Hughes Medical Institute fully exited AB InBev in Q3 2015, selling an estimated $4.83M.
- Howard Hughes Medical Institute's ten largest holdings make up 63% of its $535M portfolio in Q3 2015.
- Howard Hughes Medical Institute opened 34 new positions and closed 37 in Q3 2015.
- Howard Hughes Medical Institute's portfolio value rose 13% quarter-over-quarter to $535M.
Based on Howard Hughes Medical Institute's 13F filing for Q3 2015, filed 16 Nov 2015.